<p>The MB cell lines PFSK (A), UW228 (B) and DAOY (C) grown in serum-containing medium were incubated with increasing concentrations of cisplatin in presence or absence of the IGF-1R antibody R1507 (25 µg/ml or 50 µg/ml). Cell proliferation was assessed using the MTS assay after 48 h. The data represent the mean of 6 replicates with SD from 3 independent experiments.</p
<p>MOSE cells with specific inactivation of <i>Brca1</i>, <i>p53</i>, and/or <i>Rb</i> in various co...
<p>HSC-3 cells were plated at 1×10<sup>5</sup> cells/well in 24 well dishes, and then cultured for 2...
<p>Human SK-N-BE2c NB cells were treated with or without 1 µM cisplatin for 2 h. Cells were washed t...
<p>NB cells grown in serum-containing medium were incubated with the IGF-1R antibody R1507 (0.1 μg/m...
<p>A panel of NB cell lines (A) and MB cell lines (B) were incubated with increasing concentrations ...
<p>The R1507-insensitive cell line DAOY was incubated with increasing concentrations of the EGFR inh...
<p>A) Colony assay. The indicated cell lines were treated with ½ of the IC<sub>50</sub> dose of AZD2...
<p><b>A</b>) LD<sub>50</sub> for cisplatin determined for the SAOS-2 cells. An LD<sub>50</sub> of 10...
<p>A. MDA-MB-231 cells were exposed to cisplatin (in indicated concentrations) in the absence or pre...
<p><b>A.</b> Transfected cells were incubated with or without cisplatin for 24 hours. The cells were...
<p>Immuno-histochemical positivity for DNMT3b and Ki67. The results are expressed as cumulative numb...
<p>MSCs were grown in the complete DMEM medium mixed with equal volume of RPMI 1640 media or with co...
<p>Cells of the HL cell line L-428 after PRAME knock-down or transfection with control vector were t...
<p>(A) Effect of cisplatin on CaSki cells growth. CaSki cells were treated with with or without cisp...
<p>Parent (PT) and cisplatin resistant (CisR) cell lines were treated with increasing concentrations...
<p>MOSE cells with specific inactivation of <i>Brca1</i>, <i>p53</i>, and/or <i>Rb</i> in various co...
<p>HSC-3 cells were plated at 1×10<sup>5</sup> cells/well in 24 well dishes, and then cultured for 2...
<p>Human SK-N-BE2c NB cells were treated with or without 1 µM cisplatin for 2 h. Cells were washed t...
<p>NB cells grown in serum-containing medium were incubated with the IGF-1R antibody R1507 (0.1 μg/m...
<p>A panel of NB cell lines (A) and MB cell lines (B) were incubated with increasing concentrations ...
<p>The R1507-insensitive cell line DAOY was incubated with increasing concentrations of the EGFR inh...
<p>A) Colony assay. The indicated cell lines were treated with ½ of the IC<sub>50</sub> dose of AZD2...
<p><b>A</b>) LD<sub>50</sub> for cisplatin determined for the SAOS-2 cells. An LD<sub>50</sub> of 10...
<p>A. MDA-MB-231 cells were exposed to cisplatin (in indicated concentrations) in the absence or pre...
<p><b>A.</b> Transfected cells were incubated with or without cisplatin for 24 hours. The cells were...
<p>Immuno-histochemical positivity for DNMT3b and Ki67. The results are expressed as cumulative numb...
<p>MSCs were grown in the complete DMEM medium mixed with equal volume of RPMI 1640 media or with co...
<p>Cells of the HL cell line L-428 after PRAME knock-down or transfection with control vector were t...
<p>(A) Effect of cisplatin on CaSki cells growth. CaSki cells were treated with with or without cisp...
<p>Parent (PT) and cisplatin resistant (CisR) cell lines were treated with increasing concentrations...
<p>MOSE cells with specific inactivation of <i>Brca1</i>, <i>p53</i>, and/or <i>Rb</i> in various co...
<p>HSC-3 cells were plated at 1×10<sup>5</sup> cells/well in 24 well dishes, and then cultured for 2...
<p>Human SK-N-BE2c NB cells were treated with or without 1 µM cisplatin for 2 h. Cells were washed t...